Heterogeneous nuclear ribonucleoprotein K and nucleolin as transcriptional activators of the vascular endothelial growth factor promoter through interaction with secondary DNA structures.

The human vascular endothelial growth factor (VEGF) promoter contains a polypurine/polypyrimidine (pPu/pPy) tract that is known to play a critical role in its transcriptional regulation. This pPu/pPy tract undergoes a conformational transition between B-DNA, single-stranded DNA, and atypical secondary DNA structures such as G-quadruplexes and i-motifs. We studied the interaction of the cytosine-rich (C-rich) and guanine-rich (G-rich) strands of this tract with transcription factors heterogeneous nuclear ribonucleoprotein (hnRNP) K and nucleolin, respectively, both in vitro and in vivo and their potential role in the transcriptional control of VEGF. Using chromatin immunoprecipitation (ChIP) assay for our in vivo studies and electrophoretic mobility shift assay (EMSA) for our in vitro studies, we demonstrated that both nucleolin and hnRNP K bind selectively to the G- and C-rich sequences, respectively, in the pPu/pPy tract of the VEGF promoter. The small interfering RNA (siRNA)-mediated silencing of either nucleolin or hnRNP K resulted in the down-regulation of basal VEGF gene, suggesting that they act as activators of VEGF transcription. Taken together, the identification of transcription factors that can recognize and bind to atypical DNA structures within the pPu/pPy tract will provide new insight into mechanisms of transcriptional regulation of the VEGF gene.

[1]  A. Phan,et al.  Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter. , 2004, Journal of the American Chemical Society.

[2]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[3]  L. Hurley,et al.  The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics , 2009, Nature Reviews Cancer.

[4]  David Levens,et al.  Heterogeneous nuclear ribonucleoprotein K is a transcription factor , 1996, Molecular and cellular biology.

[5]  R. Natarajan,et al.  Distinct Roles of Heterogeneous Nuclear Ribonuclear Protein K and microRNA-16 in Cyclooxygenase-2 RNA Stability Induced by S100b, a Ligand of the Receptor for Advanced Glycation End Products*♦ , 2008, Journal of Biological Chemistry.

[6]  L. Hurley,et al.  Intramolecularly folded G-quadruplex and i-motif structures in the proximal promoter of the vascular endothelial growth factor gene , 2008, Nucleic acids research.

[7]  Mauro Ferrari,et al.  Morphologic Instability and Cancer Invasion , 2005, Clinical Cancer Research.

[8]  C. Burrows,et al.  Cytosine-specific chemical probing of DNA using bromide and monoperoxysulfate. , 1996, Nucleic acids research.

[9]  D. Levens,et al.  The functional response of upstream DNA to dynamic supercoiling in vivo , 2008, Nature Structural &Molecular Biology.

[10]  M. Biggin,et al.  The specificity of protein-DNA crosslinking by formaldehyde: in vitro and in drosophila embryos. , 2000, Nucleic acids research.

[11]  T. Tomonaga,et al.  Activating transcription from single stranded DNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Stroud,et al.  Crystal structure of the third KH domain of human poly(C)-binding protein-2 in complex with a C-rich strand of human telomeric DNA at 1.6 Å resolution , 2007, Nucleic acids research.

[13]  H. Krutzsch,et al.  Cellular Nucleic Acid Binding Protein Regulates the CT Element of the Human c- myc Protooncogene (*) , 1995, The Journal of Biological Chemistry.

[14]  L. Regan,et al.  Structure and function of KH domains , 2008, The FEBS journal.

[15]  M. Guéron,et al.  A tetrameric DNA structure with protonated cytosine-cytosine base pairs , 1993, Nature.

[16]  M. Abdelrahim,et al.  Cyclooxygenase-2 Inhibitors Decrease Vascular Endothelial Growth Factor Expression in Colon Cancer Cells by Enhanced Degradation of Sp1 and Sp4 Proteins , 2005, Molecular Pharmacology.

[17]  Brad Saville,et al.  Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor α and SP proteins , 2004, Oncogene.

[18]  Yong You,et al.  Predicting ultraviolet spectrum of single stranded and double stranded deoxyribonucleic acids. , 2008, Biophysical chemistry.

[19]  Jerzy Ostrowski,et al.  hnRNP K: One protein multiple processes , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[20]  M. Abdelrahim,et al.  Role of Sp Proteins in Regulation of Vascular Endothelial Growth Factor Expression and Proliferation of Pancreatic Cancer Cells , 2004, Cancer Research.

[21]  M. Takagi,et al.  Regulation of p53 Translation and Induction after DNA Damage by Ribosomal Protein L26 and Nucleolin , 2005, Cell.

[22]  L. Marky,et al.  Calorimetric unfolding of the bimolecular and i-motif complexes of the human telomere complementary strand, d(C(3)TA(2))(4). , 2007, Biophysical chemistry.

[23]  Napoleone Ferrara,et al.  Angiogenesis as a therapeutic target , 2005, Nature.

[24]  K. Kihara,et al.  Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids , 2004, Molecular and Cellular Endocrinology.

[25]  H. Leffers,et al.  Identification of two human nuclear proteins that recognise the cytosine-rich strand of human telomeres in vitro. , 2000, Nucleic acids research.

[26]  D. Patel,et al.  Guanine residues in d(T2AG3) and d(T2G4) form parallel-stranded potassium cation stabilized G-quadruplexes with anti glycosidic torsion angles in solution. , 1992, Biochemistry.

[27]  M. Borgognone,et al.  Cellular nucleic-acid-binding protein, a transcriptional enhancer of c-Myc, promotes the formation of parallel G-quadruplexes. , 2010, The Biochemical journal.

[28]  J. Abbruzzese,et al.  Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. , 2001, Cancer research.

[29]  L. Hurley,et al.  The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex–interactive agents , 2008, Molecular Cancer Therapeutics.

[30]  Daniela Rhodes,et al.  G-quadruplex structures: in vivo evidence and function. , 2009, Trends in cell biology.

[31]  G. Siemeister,et al.  Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression , 1997, Oncogene.

[32]  Daekyu Sun,et al.  Identification and Characterization of Nucleolin as a c-myc G-quadruplex-binding Protein* , 2009, The Journal of Biological Chemistry.

[33]  G. Dreyfuss,et al.  Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro. , 1993, The Journal of biological chemistry.